BioM's articles about and for the Bavarian biotechnology sector
SIRION BIOTECH GmbH
MorphoSys's Licensee Janssen Announces Data from the Phase 3 Head-to-Head Study ECLIPSE Demonstrating Superiority of Tremfya(R) vs. Cosentyx(R) as Measured by PASI 90 at Week 48 in the Treatment of Plaque Psoriasis
AdvanceCOR GmbH announces completion of recruitment of patients with symptomatic stenosis of the carotid artery suffering from ischemic stroke in a clinical phase II study on Revacept vs. placebo
Ad hoc: MorphoSys Announces that According to a Presentation Title at an Upcoming Conference, Guselkumab Demonstrates Superior Long-Term Responses to Secukinumab at Week 48 in the Treatment of Moderate to Severe Psoriasis
Would you like to enter or update data?
Request login data